Study to Identify the Genetic Variations Associated With Phantom Limb Pain
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine if there is a genetic component to phantom limb pain. DNA will be analyzed for single nucleotide polymorphisms (SNPs) between the control and phantom limb pain group. Total RNA will also be isolated and profiled to asses the degree to which our gene(s) of interest are expressed in the presence or absence of phantom limb pain. Some proteins, such as inflammatory antibodies or the neurotrophin brain-derived neurotrophic factor (BDNF), will also be assessed for their association(s) with phantom limb pain.
Research Team
Paul F. Pasquina, MD, MC
Principal Investigator
Walter Reed National Military Medical Center (WRNMMC)
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- Blood Draw (Other)
- DNA Analysis (Genetic Testing)
- Protein Analysis (Protein Analysis)
- RNA Analysis (Gene Expression Profiling)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Henry M. Jackson Foundation for the Advancement of Military Medicine
Lead Sponsor
Uniformed Services University of the Health Sciences
Collaborator